Abstract
The US orthopedic biomaterial market, comprising bone graft substitutes,
hyaluronic acid viscosupplementation, machined bone interbody devices, knee
cartilage repair grafts and devices, and cell concentration systems was valued
at nearly $2.5 billion in 2008.
| 
View Cart
